介入放射学在遗传性出血性毛细血管扩张症治疗中的作用
遗传性出血性毛细血管扩张症(HHT)是一种罕见的常染色体显性多器官疾病,可导致异常血管连接并引发严重并发症。本文综述了HHT的临床表现、诊断指南和标准,并介绍了血管内治疗在HHT患者管理中的手段,强调介入放射学在维持患者健康和降低致命并发症风险中的关键作用。
要点
- HHT诊断需结合临床标准,介入放射学在管理血管并发症中起核心作用。
- 血管内治疗是HHT相关异常血管连接的重要治疗手段。
- 多学科协作对HHT的诊断和治疗至关重要。
临床应用与阅片要点
- 阅片时注意识别HHT相关的异常血管连接,如动静脉畸形。
- 介入放射学手段可用于HHT并发症的血管内治疗。
- 诊断HHT需结合临床指南和标准,多学科协作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hereditary hemorrhagic telangiectasia (HHT) also known as Osler-Weber-Rendu disease is a rare autosomal dominant, multi-organ disorder that leads to formation of abnormal vascular connections resulting in devastating and life-threatening complications. Due to its multisystem character, wide range of clinical manifestations and variable expressivity, HHT remains a diagnostic challenge and requires close cooperation of specialists from various medical fields. Interventional radiology plays a key role in the management of this disease, helping maintain the health of HHT patients and minimize the risk of fatal complications. The aim of this article is to review clinical manifestations, diagnostic guidelines and criteria of HHT as well as to present the means of endovascular therapy in the management of HHT patients.
引用
- Szmygin, Szmygin, Drelich, et al. The role of interventional radiology in treatment of patients with hereditary hemorrhagic telangiectasia. Eur J Radiol. 2023. PMID: 36933496. doi:10.1016/j.ejrad.2023.110769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。